Young adults with asthma including >12 episodes of wheeze, asthma, and high eosinophil counts, or asthma and IgE sensitization all had decreased odds of receiving ≥2 and ≥3 doses in the adjusted models compared to peers without asthma and those characteristics. This evidence concerns the gene IGHE and asthma.